Renovorx, Inc. current report, 02 January 2024

RenovoRx, Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by RenovoRx, Inc. on January 2, 2024, reporting an event that occurred on December 26, 2023. The Company is an emerging growth company incorporated in Delaware.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report does not contain financial statements or performance metrics.

Material Changes

The material change reported is the passing of David Diamond, a member of the Board of Directors, on December 26, 2023. Mr. Diamond had served the Company since May 2021 and held the following key roles:

  • Chair of the Audit Committee
  • Member of the Compensation Committee
  • Lead Independent Director

The Board intends to seek a replacement for Mr. Diamond in due course.

Outlook, Risks, and Management Commentary

Management expressed deep sadness regarding the loss of Mr. Diamond and extended sympathies to his family. No specific financial guidance, operational outlook, or new risk factors were disclosed in this filing.

Key Facts for Investor Verification

  • Confirmation of the date of passing for Board member David Diamond (December 26, 2023).
  • Timeline for the appointment of a replacement director to the Board.
  • Impact of the vacancy on the composition of the Audit and Compensation Committees.